SGLT2 Inhibitors: A Future in Cardiorenal Metabolic Syndrome

preview_player
Показать описание
Join Drs Nihar Desai and Jay Udell as they discuss the role of SGLT2 inhibitors in the treatment of cardiorenal metabolic syndrome.




Resources


















Рекомендации по теме
visit shbcf.ru